Latest Indegene stock price

Indegene P/E Ratio

INDGN • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
28.07
High Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 28.07
Current Price ₹509.90
EPS (TTM) ₹17.15
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 34.62
Historical Range 34.62 - 34.62
Percentile 0.0%

Sector Context

Sector Average 53.59
Sector Median 31.12
Sector Rank #11 of 131
Sector Percentile 8.4%

Earnings Breakdown (TTM)

TTM EPS ₹17.87
Sept 2025 ₹4.26
Mar 2025 ₹4.91

Key P/E Ratio Insights for Indegene

  • Stock appears overvalued with PE of 28.07, suggesting caution for new investments
  • Trading at discount to sector average PE of 53.59

View the INDGN equity price for detailed stock performance.

P/E Ratio Historical Trend for Indegene

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 34.62 16.49 ₹570.90 NSE High

Sector P/E Ratio Comparison

Comparing Indegene with other companies in Healthcare sector
Sector Average
53.59
Sector Median
31.12
Lowest P/E
1.5
Highest P/E
628.04
Companies
131
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.5 ₹51 Low
Ind Swift Laboratories INDSWFTLAB 3.18 ₹733 Low
Murae Organisor MURAE 3.86 ₹55 Low
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Zenith Drugs ZENITHDRUG 9.06 ₹84 Low
Galaxy Medicare GML 9.5 ₹32 Low
Balaxi Pharmaceuticals BALAXI 10.06 ₹139 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Vasundhara Rasayans VRL 11.3 ₹51 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low